US Patent Issued to Griffith University, Research Institute at Nationwide Children's Hospital on March 3 for "Agents and methods for modulating pathogen activity" (Australian, American Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,596, issued on March 3, was assigned to Griffith University (Nathan, Australia) and Research Institute at Nationwide Children's Hospital (Columbus, Ohio).

"Agents and methods for modulating pathogen activity" was invented by Michael P. Jennings (Nathan, Australia), Jennifer L. Edwards (Columbus, Ohio), Christopher J. Day (Nathan, Australia) and Johnson Mak (Nathan, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor, are useful in methods, compositions and articles/devices for inhibiting the interaction of pathogens to a complement receptor...